Colorado Weighs Bill Nixing Orphan Drugs From PDAB Review

By Luke Zarzecki / February 22, 2024 at 10:16 AM
After Colorado’s prescription drug affordability board (PDAB) ruled Trikafta “not unaffordable” largely in part from patient assistance programs offered by the manufacturer, a bill introduced in the state’s legislature would not allow for Trikafta -- or any other orphan drug -- from being considered by the new board. Colorado’s PDAB said in its report that it would consider reviewing Trikafta in the future if patients’ access to the drug subsided. Pharmaceutical Research and Manufacturers of America has donated over $800,000...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.